There is a rich literature on the contribution of some of our identified hub genes in CRC and less evidence in support of some others such as LHX2, ZFPM1, and DPYSL2. For instance, the differences in tumor and corresponding adjacent benign tissues regarding LHX gene expressions have been investigated93. This evidence concerns the gene ZFPM1 and neoplasm.